BACKGROUND: Malaria in pregnancy is a significant cause of maternal and infant morbidity and mortality. Malawi adopted intermittent preventive treatment with sulfadoxinepyrimethamine (SP) for the control of malaria in pregnancy in 1993. However there is little information on the in-vivo SP efficacy in pregnant women. This study was conducted to determine: prevalence of malaria and anaemia at the first antenatal visit and rate of parasitological failure to SP in pregnancy. METHODS: A cross-sectional followed by a prospective cohort study was conducted in women attending antenatal care clinic at Montfort Hospital in Lower Shire Valley from June 2004 to February 2005. Women were screened for malaria and anaemia at the first antenatal visit. After taking SP under direct observation, women with malaria parasitaemia were followed up to day 14 to determine parasitological response. RESULTS: Of 961 women screened, 9% had malaria, 77% had anaemia (HB<11.0g/dl), 24% had moderate anaemia (HB 7.0-8.9g/dl) and 6% had severe anaemia (HB<7.0g/dl). Malaria was significantly more frequent in primigravidae, the second trimester and in the post- rainy season (all p <0.05). Moderate anaemia (Hb < 9.0g/dl) was significantly more common in adolescents and primigravidae (both p <0.05). In the14-day follow up study, loss to follow up was 13%. Of the 74 women who completed the follow up, 89% cleared malaria parasites successfully and 11% had parasitological failure. Parasitological failures were all of the R1 type except for one with R2 failure. CONCLUSION: Anaemia prevalence was high at first antenatal visit in this population. Rate of parasitological failure to SP in pregnancy increased from 5% in 1996 to 11% in 2004.
BACKGROUND:Malaria in pregnancy is a significant cause of maternal and infant morbidity and mortality. Malawi adopted intermittent preventive treatment with sulfadoxinepyrimethamine (SP) for the control of malaria in pregnancy in 1993. However there is little information on the in-vivo SP efficacy in pregnant women. This study was conducted to determine: prevalence of malaria and anaemia at the first antenatal visit and rate of parasitological failure to SP in pregnancy. METHODS: A cross-sectional followed by a prospective cohort study was conducted in women attending antenatal care clinic at Montfort Hospital in Lower Shire Valley from June 2004 to February 2005. Women were screened for malaria and anaemia at the first antenatal visit. After taking SP under direct observation, women with malaria parasitaemia were followed up to day 14 to determine parasitological response. RESULTS: Of 961 women screened, 9% had malaria, 77% had anaemia (HB<11.0g/dl), 24% had moderate anaemia (HB 7.0-8.9g/dl) and 6% had severe anaemia (HB<7.0g/dl). Malaria was significantly more frequent in primigravidae, the second trimester and in the post- rainy season (all p <0.05). Moderate anaemia (Hb < 9.0g/dl) was significantly more common in adolescents and primigravidae (both p <0.05). In the14-day follow up study, loss to follow up was 13%. Of the 74 women who completed the follow up, 89% cleared malaria parasites successfully and 11% had parasitological failure. Parasitological failures were all of the R1 type except for one with R2 failure. CONCLUSION:Anaemia prevalence was high at first antenatal visit in this population. Rate of parasitological failure to SP in pregnancy increased from 5% in 1996 to 11% in 2004.
Authors: J MacArthur; G M Stennies; A Macheso; M S Kolczak; M D Green; D Ali; L M Barat; P N Kazembe; T K Ruebush Journal: Am J Trop Med Hyg Date: 2001-12 Impact factor: 2.345
Authors: J Sulo; P Chimpeni; J Hatcher; J G Kublin; C V Plowe; M E Molyneux; K Marsh; T E Taylor; W M Watkins; P A Winstanley Journal: Lancet Date: 2002-10-12 Impact factor: 79.321
Authors: M Takechi; M Matsuo; C Ziba; A MacHeso; D Butao; I L Zungu; I Chakanika; M D Bustos Journal: Trop Med Int Health Date: 2001-06 Impact factor: 2.622
Authors: O C Nwanyanwu; C Ziba; P Kazembe; L Chitsulo; J J Wirima; N Kumwenda; S C Redd Journal: Trop Med Int Health Date: 1996-04 Impact factor: 2.622
Authors: Christopher V Plowe; James G Kublin; Fraction K Dzinjalamala; Deborah S Kamwendo; Rabia A G Mukadam; Phillips Chimpeni; Malcolm E Molyneux; Terrie E Taylor Journal: BMJ Date: 2004-02-02
Authors: Julie Gutman; Dyson Mwandama; Ryan E Wiegand; Joseph Abdallah; Nnaemeka C Iriemenam; Ya Ping Shi; Don P Mathanga; Jacek Skarbinski Journal: Malar J Date: 2015-05-13 Impact factor: 2.979
Authors: Chikondi Mwendera; Christiaan de Jager; Herbert Longwe; Kamija Phiri; Charles Hongoro; Clifford M Mutero Journal: Health Res Policy Syst Date: 2016-06-01